In Brief
Avoiding infection as a consequence of immunosuppression following organ transplantation has been elusive. Here, Jayachandran et al. demonstrate that targeting the immunoregulatory protein coronin 1 in mice results in allograftspecific tolerance in the absence of immunosuppression-associated comorbidities. Coronin 1-deficiency increased cAMP concentrations to suppress allo-specific T cell responses without compromising pathogen-specific immunity and may represent an attractive therapeutic target.
INTRODUCTION
The ability of a vertebrate host to initiate T cell responses toward pathogenic microbes relies on the appropriate recognition of antigenic peptides presented on antigen-presenting cells (APC's) via an individual's own major histocompatibility complex (MHC) molecules (Zinkernagel and Doherty, 1979) . The MHC molecules are by far the most polymorphic known, possibly having evolved to prevent pathogens from escaping immune detection while avoiding reactivity against ''self'' (Doherty and Zinkernagel, 1975) . To achieve this, T cells are selected in the thymus in order to delete auto-reactive T cells and allow only those cells to reach the periphery that lack reactivity toward self and can recognize foreign peptides in the context of self-MHC (Doherty and Zinkernagel, 1975; Goldrath and Bevan, 1999; Huseby et al., 2005) . The polymorphic nature of the MHC molecules allows the recognition of a large variety of antigenic peptides, but has the consequence that, with the exception of identical twins, there are rarely two individuals who carry exactly the same set of MHC genes and molecules thus resulting in a virtual inability to accept allografts; this problem is further exacerbated by the existence of minor histocompatibility antigens (Goulmy et al., 1996) .
T cells that are exported from the thymus are maintained in the periphery through pro-survival signals that are delivered through the T cell receptor (TCR) by self-peptide:MHC interaction as well as interleukin-7 signaling (Surh and Sprent, 2008) . Recent work has suggested the presence of a third axis required for naive T cell homeostasis that relies on the activity of the WD repeat protein coronin 1 (also known as P57 or Tryptophan Aspartate containing COat (TACO) protein) (Fö ger et al., 2006; Mueller et al., 2008; Shiow et al., 2008) . In the absence of coronin 1, naive T cells are depleted while other leukocytes remain functional and exist in normal numbers, although coronin 1 may play a role in the functionality of natural killer cells and neutrophils (Arandjelovic et al., 2010; Combaluzier et al., 2009; Combaluzier and Pieters, 2009; Haraldsson et al., 2008; Jayachandran et al., 2007; Mace and Orange, 2014; Pick et al., 2017; Siegmund et al., 2013; Tchang et al., 2017; Westritschnig et al., 2013) . Coronin 1 is dispensable for T cell differentiation, selection, and export to secondary lymphoid organs (Lang et al., 2017) , suggesting that coronin 1 mediates T cell homeostasis through an as-yet-undefined mechanism.
Here, we describe an essential role for coronin 1 in allograft rejection via the modulation of the phosphodiesterase 4-CREBCaMKIV pathway in T cells. We found that coronin 1 maintains appropriate levels of cAMP, similar to its role in regulating the cAMP-protein kinase A pathway in neurons and Dictyostelium (via its ortholog coronin A, Jayachandran et al., 2014; Vinet et al., 2014) . Suppression was specific for alloresponses, since infection-mediated CD28 ligation through CD80 could overcome cAMP-mediated suppression of T cell responses. Finally, we describe that this pathway could be targeted in vivo, suggesting a potential for interfering with this pathway to achieve long-term graft acceptance without compromising immunity to infections.
RESULTS

Mice Lacking Coronin 1 Are Tolerant of Allografts but Maintain Immunity against Microbial Pathogens
Deletion of coronin 1 in mice results in a specific and selective depletion of peripheral mature naive T cells. To understand the relative importance of the coronin 1-dependent T cell subset for alloresponses versus immunity toward pathogenic microbes, mice lacking coronin 1 were subjected to transplantation and microbial challenges.
For transplantations, MHC mismatched donor hearts (BALB/c, I-A d ) were transplanted into C57BL/6 wild-type (WT) or coronin 1-deficient (Coro1a À/À , see also Pieters et al., 2013 for nomenclature) mice (I-A b ) by grafting BALB/c cardiac allografts onto the abdominal aorta (Niimi 2001) . While allografts were rapidly rejected in all WT recipients by day 8, in Coro1a À/À recipients BALB/c hearts remained fully functional until study termination at 106 days ( Figures 1A-1C) . Histology of the BALB/c hearts revealed severe vasculopathy in WT recipients (on day 8), whereas Coro1a À/À mice showed only minimal vascular changes (on day 106, with beating hearts) (Figures 1B and 1C) . One of the most challenging organs in terms of allograft retention is skin because of its highly immunogenic nature (Richters et al., 2005) . To analyze a role for coronin 1 in skin graft rejection, skin grafts representing both major (H2-bm12 (I-A bm12 )); Figures 1D-1F) (McKenzie et al., 1979) or minor histocompatibility antigen-mismatch (BALB/c d ) (Figures 1G and S1A) were transplanted onto either C57BL/6 WT or Coro1a À/À mice (I-A b ). Similar to the results described above, Coro1a À/À mice allowed long-term retention of the skin allografts whereas all WT recipients rejected rapidly . (Figures S1E and S1F) consistent with previous data from an irradiated model (Fulton et al., 2014; Krenger et al., 2000b) . Together these results suggest the occurrence of long-term allograft acceptance in the absence of coronin 1. In contrast to the tolerance toward allografts, deficiency of coronin 1 allowed appropriate responses against a range of pathogenic microbial challenges: when infected with S. aureus or C. albicans, Coro1a
À/À mice cleared the microbial load as observed for WT mice (Figures 2A and 2B and Figures S2A and S2B) , and similar results were seen with intravenous administration of S. aureus ( Figure S2C ), a model for persistent infection (Ziegler et al., 2011) . Infection with virulent S. typhimurium resulted in comparable mouse survival kinetics and bacterial burden in spleen and liver ( Figure 2C and Figure S2E ). To assess T cell-specific responses, we generated Coro1a À/À OTII transgenic mice whose T cells express a T cell receptor that specifically recognizes an ovalbumin peptide in the context of I-A b .
Upon infection with ovalbumin-expressing S. typhimurium, both WT and Coro1a À/À OTII T cells underwent specific proliferation and expansion, suggesting that Coro1a À/À T cells could recognize and mount adaptive immune responses. Both genotypes could be protectively vaccinated against virulent Salmonella, a process that depends on CD4
+ -specific T cell responses (Kupz et al., 2014; Ravindran and McSorley, 2005) (Figure 2E ). The responses against a challenge with murine cytomegalovirus (the virulent MCMV-DM157 strain that does not activate NK cells; Bubi c et al., 2004; Walton et al., 2008) and whose control is critically dependent on T cell responses (Klenerman and Oxenius, 2016; Verma et al., 2015) was similar in liver and lungs, with a slight delay in clearance in spleen and salivary glands ( Figure 2F ) accompanied by the occurrence of specific T cell responses (Figure 2G) . Mice lacking coronin 1 showed an overall health similar to WT mice, including life expectancy, absence of malignancies, comparable composition of viral, bacterial, and parasitic flora (Tables S1 and S2 , Figures S2D and S2F ). These data suggest that the observed allograft acceptance is not due to an overall reduction in T cell effector function but rather a T cell-intrinsic defect when reacting to major and minor alloantigens. (Josefowicz et al., 2012; Sakaguchi et al., 2008; Tang and Bluestone, 2013) . To assess whether the observed long-term allograft acceptance in Coro1a À/À mice was mediated by Treg cells, mice were treated with PC61 antibodies ( Figure S4A ) that effectively depleted CD4 + CD25 + Treg cells ( Figure S4B ). Treg cell depletion failed to induce allograft rejection ( Figure 3C) Table S3 ), consistent with the recently described capacity of coronin 1 to modulate the cAMP pathway (Jayachandran et al., Suo et al., 2014) . cAMP modulates T cell immune responses (Bourne et al., 1974; Mosenden and Taské n, 2011) and plays a role in the suppressive activity of T cells (Bopp et al., 2007) . To analyze a possible role for coronin 1 in the modulation of cAMP signaling in T cells, membranes from WT and Coro1a À/À T cells were stimulated with forskolin and cAMP levels were determined. Depletion of coronin 1 resulted in significantly reduced production of cAMP ( Figures S5C and S5D ). However, when intracellular concentrations of cAMP were determined, Coro1a À/À T cells showed enhanced levels of cAMP relative to WT T cells (Figures 4A and 4B) . The fact that activation or inhibition of components of the cAMP pathway is known to result in compensatory modulation of other proteins in this pathway (Erdogan and Houslay, 1997; Krumins and Gilman, 2006) , prompted us to analyze levels of the cAMP degrading phosphodiesterase 4 (PDE4), a key regulator of cAMP in T cells (Erdogan and Houslay, 1997; Giembycz et al., 1996; Omori and Kotera, 2007) . PDE4 protein amounts were severely reduced in T cells lacking coronin 1 ( (H) Immunofluorescence analysis of coronin 1 in WT and Coro1a À/À Jurkat T cells by using an a-coronin 1 antibody, followed by staining with Alexa Fluor 568 conjugated secondary antibody. Nuclei were stained using DRAQ5. Scale bar = 10 mm. Three independent experiments. (I) WT or Coro1a À/À Jurkat cells were lysed and equal protein amounts immunoblotted for PDE4 followed by reprobing with a-coronin 1 and a-actin antibodies.
Representative blot from three independent experiments. stimulation of T cells with the adenylate cyclase activator forskolin resulted in elevated cAMP concentrations in T cells lacking coronin 1 ( Figure 4D ). The inclusion of the PDE4 inhibitor rolipram, which enhanced the fold induction of cAMP in WT T cells, did not do so in Coro1a À/À T cells upon stimulation (Figure 4E) . This suggests that the absence of coronin 1 resulted in elevated cAMP levels as a result of a compensatory decrease in PDE4 protein in T cells. Analysis of migrated healthy naive T cells as well as memory T cells (Mueller et al., 2011) revealed elevated cAMP concentrations in all Coro1a À/À T cell subsets (Figures 4F and 4G) . Also, human T cells (Jurkat) lacking coronin 1 through CRISPR-Cas9-mediated deletion of the Coro1a gene showed a similar reduction of PDE4 protein as well as enhanced cAMP concentration ( Figures 4H-4J ), confirming that the role of coronin 1 in regulating cAMP-PDE4 levels is T cell intrinsic. Coronin 1-mediated cAMP modulation was furthermore found to occur in primary human immune cells, as peripheral blood mononuclear cells (PBMC) from a human subject harboring a destabilizing V134M mutation in coronin 1 (Jayachandran et al., 2014; Moshous et al., 2013) showed reduction of PDE4 protein and increased cAMP concentration ( Figures 4K-4N ). Thus, our findings suggest a critical role for coronin 1 in maintaining the levels of cAMP in both mouse and human T cells in a cell-intrinsic manner.
To further delineate coronin 1-dependent regulation of cAMP signaling in T cells, we analyzed the activity as well as localization of protein kinase A (PKA), a serine/threonine kinase whose regulatory subunits bind cAMP (Taylor et al., 2005) . Consistent with increased cAMP levels in the absence of coronin 1, lysates from Coro1a À/À T cells showed elevated levels of PKA activity ( Figure 5A ), and the catalytic subunit of PKA (PKAc) was translocated to the nucleus in the absence of coronin 1 ( Figure S5F ). In T cells, increases in cAMP levels inhibit the activation of CalModulin Kinase IV (CaMKIV) by blocking its phosphorylation at Thr-196 (Soderling, 1999; Wayman et al., 1997) . Consistent with elevated PKA activity in Coro1a À/À T cells, CaMKIV (T  196 ) phosphorylation was reduced ( Figure 5B ). CaMKIV is one of the prime kinases needed for the activation of the cAMP Response Element Binding (CREB) protein in T cells (Anderson and Means, 2002; Anderson et al., 1997) , and phosphorylation of CREB (S 133 ) was impeded in the absence of coronin 1 ( Figures  5C-5E ). To address the role for PKA and CaMKIV in the phosphorylation of CREB in unstimulated T cells in vivo, freshly isolated cells were immediately incubated with or without inhibitors for PKA or CaMKIV. Blocking PKA (with H89) in Coro1a À/À T cells resulted in an increase in CREB phosphorylation, whereas blocking CaMKIV with KN93 further reduced the pCREB status ( Figure 5F ). While inhibition of PKA did not affect proliferation of WT T cells, it significantly enhanced the proliferation of Coro1a À/À T cells ( Figure 5G ).
To analyze whether modulation of cAMP could alter T cell numbers in vivo, we manipulated cAMP levels through administration of the phosphodiesterase inhibitor rolipram in WT mice (elevating cAMP) or treated Coro1a À/À mice with the PKA inhibitor H89 (reducing cAMP). Administration of rolipram in WT mice significantly reduced naive T cell numbers ( Figure 5H ), whereas administration of H89 to inhibit cAMP-PKA signaling in Coro1a À/À T cells resulted in a significant increase in naive T cell numbers ( Figure 5I ). S6D ). Blocking CD80-mediated co-stimulation using blocking antibodies, either alone or together with CD86, prevented anti-infectious responses even in the presence of rolipram, suggesting a role for CD80-mediated T cell activation in overcoming cAMP mediated immunosuppression ( Figures 6D and S6D ). Exclusion of CD28 co-stimulation in the context of TCR triggering ( Figure 6E ) rendered T cells vulnerable to inhibition of proliferation by rolipram (IC 50 of$20 mM for CD3 stimulus versus > 320 mM for CD3-28 stimuli), suggesting the ability of CD80-CD28 signaling to overcome the cAMP-mediated inhibition of immune responses during microbial infections. Coro1a À/À antigen presenting cells were equally capable of triggering allogeneic T cells to proliferate ( Figure S6F ). These results show the potential for elevating cAMP levels inside T cells through coronin 1 depletion to selectively block alloresponses while maintaining anti-infectious responses.
Coro1a
-/-CD4 + CD25 -Tconv Cells Induce Tolerance against Alloreactive T Cells The specific suppression of alloreactivity, without compromising immunity against microbial pathogens, led us to explore whether Coro1a À/À T cells were able to induce tolerance against allografts. To analyze a potential for pharmacological manipulation of this pathway to modulate graft rejection, cAMP levels were manipulated in vivo through administration of the PDE inhibitor rolipram in mice bearing a major MHC mismatched skin allograft (BM12 I-A bm12 ). Administration of rolipram resulted in significantly prolonged survival of allografts in comparison to vehicle only-treated control ( Figure 7C ). Administration of the PKA inhibitor H89 in vivo in Coro1a À/À mice bearing a major MHC-mismatched allograft that had been adoptively transferred with wild-type CD4 T cells reversed the allograft tolerance (Figure 7D) . These results suggest that modulation of the coronin 1-dependent axis may be beneficial in the prevention of allograft rejection.
DISCUSSION
One of the most problematic consequences of immunosuppression following allograft transplantation is the association with a Representative blot from three independent experiments. (C) Equal amounts of splenic T cell lysates from WT or Coro1a À/À mice were immunoblotted for phosphoCREB (S 133 pCREB), total CREB, actin and coronin 1.
Representative blot from four independent experiments. (D and E) T cells from WT and Coro1a
À/À spleens were mixed in a 1:1 ratio on a coverslip and stained for pCREB (AF488), coronin 1 (AF568) and DRAQ5 and imaged by confocal microscopy. Scale bar = 8 mm. high susceptibility toward pathogenic and opportunistic infections (Avery, 2013; Birkeland et al., 2000) . Mechanisms allowing a selective suppression of allo-reactive T cells while avoiding suppression of pathogen-specific immune cell responses are currently unknown. Here, we show that deletion in mice of the gene coding for coronin 1, an essential regulator of peripheral naive T cells, results in tolerance toward allografts while maintaining robust immune responses against a range of pathogenic microbes as well as an absence of immunosuppression-mediated pathology. We further show that the here described tolerance toward allografts is linked toward a role for coronin 1 in modulating the CaMKIV-pCREB pathway and that the absence of coronin 1 in T cells resulted in upregulation of cAMP and increased activity of PKA, thereby blocking CaMKIV and resulting in reduced CREB phosphorylation. The elevated levels of cAMP are likely to be a result of adaptive changes in T cells induced by the absence of coronin 1, that is known to modulate cAMP responses following cell surface stimulation (Jayachandran et al., 2014; Suo et al., 2014) . Indeed, deletion and/or inhibition of components of the cAMP-PKA pathway modulate levels of other proteins that play a role in this pathway (Dupré et al., 2009; Erdogan and Houslay, 1997; Krumins and Gilman, 2006) . In particular, we found that Coro1a À/À T cells expressed reduced amounts of the cAMP degrading enzyme PDE4, a central regulator of cAMP in T cells (Arumugham and Baldari, 2017 The paucity of peripheral naive T cells in the absence of coronin 1 in mice did not result in a predisposition toward infections. This suggests that a minimal number of naive T cells may be sufficient to effectively control these pathogens, including the generation of specific T cell responses, although coronin 1 may be required to contain infections where the timing or rapid clearance of pathogens at specific niches is crucial as seen following MCMV infection. Although Coro1a À/À individuals have been reported to display an enhanced susceptibility toward infections, in most of these cases additional genetic aberrations are present, such as those in genes involved (C) WT C57BL/6 mice carrying a major MHC mismatched skin allograft (BM12 skin grafts, I-A bm12 ) were treated either with rolipram or the control vehicle and monitored for kinetics of allograft rejection. P values (**p < 0.001) were calculated using Mantel-Cox log-rank test. n = 8 mice for rolipram treated group. n = 4 mice per group for untreated and DMSO treated group. (D) Survival of BM12 RAG2 À/À skin grafts in Coro1a À/À recipients after transfer of WT C57BL/6 with application of either DMSO or the PKA inhibitor H89. Following transplantation, the recipient mice were adoptively transferred with CD4 + T cells i.v. on day 0 day. H89 application (40 mg/kg body weight) was initiated a day prior to the day of adoptive transfer. n = 3 mice for DMSO group, 4 mice for H89 group, n = 3 mice for rejection control RAG2 À/À with WT CD4 AT group. p = 0.07, Logrank test between DMSO and H89 group. See also Figure S7 .
in the regulation of immune function (NLRP7, STAT2, NCF2, APOB48R; Punwani et al., 2015; Shiow et al., 2009; Stray-Pedersen et al., 2014; Yee et al., 2016) . Whether or not in human, as opposed to mice, coronin 1 loss-of-function is associated with infectious complications such as susceptibility to certain viruses (Moshous et al., 2013; Stray-Pedersen et al., 2014) or whether additional confounding factors are responsible for the observed susceptibility remains to be analyzed. The exact role for cAMP in promoting immunosuppression remains to be elucidated. cAMP is known as a negative regulator of T cell activation (Bourne et al., 1974; Wehbi and Taské n, 2016) , and immunosuppressive activities of cAMP have predominantly been ascribed to its capacity to block proximal TCR signaling (Vang et al., 2001; Wehbi and Taské n, 2016) . However, proximal TCR signaling appears to be unaltered in the absence of coronin 1 (Mueller et al., 2008) , which is also consistent with normal T cell selection in the thymus (Lang et al., 2017; Mueller et al., 2008) as well as the here described normal T cell responses against microbial pathogens. While Coro1a À/À T cells were also reported to be defective in the activation of the calcineurin signaling pathway (Mueller et al., 2011; Mueller et al., 2008) , this cannot explain the suppression of WT T cells from allograft rejection by Coro1a À/À T cells as tween Coro1a À/À and WT T cells; however, our attempts to asses a direct contact using an in vivo transfer assay (Bodor et al., 2012) were unsuccessful. Possibly, activation of the cAMP-PKA pathway upon coronin 1 deletion induces the release of molecules in an autocrine or paracrine manner or in trans as evidenced by the upregulation of immunosuppressive markers. Such a scenario would be consistent with the here shown capacity of Coro1a À/À T cells to suppress WT
T cells in vivo.
While T cell responses toward allografts are suppressed, immunity against pathogenic microbes was unperturbed in the absence of coronin 1. This was found to be due to the ability of CD28-dependent co-stimulation through CD80, but not CD86, to overcome cAMP-mediated suppression following microbial infection. Interestingly, CD80 and CD86 activate distinct signaling pathways, and although the exact roles of CD80 and CD86 activation of CD28 during allograft immune responses remain unclear (Ford, 2016; Zheng et al., 1997) , the data presented here provide support for a role of CD80 in T cell activation toward microbial antigens, even in the presence of the immunosuppressive molecule cAMP.
The here defined role for coronin 1 in the induction of a tolerogenic environment while maintaining immunity against microbial pathogens opens an interesting perspective for developing immunosuppressive strategies. Current regimens employed to prevent graft rejection largely depend on the use of calcineurin blockers. Given the ubiquitous expression of calcineurin and its importance in diverse physiological processes, calcineurin inhibitors are associated with severe side effects including infections and malignancies. Furthermore, recent work exploring modulation of co-stimulatory and co-inhibitory pathways lead to the realization that such approaches may also perturb Treg cell homeostasis, with enhanced rejection and the potential to develop autoimmunity (Ford, 2016; Schmidt et al., 2009 ). In contrast, depletion of coronin 1, at least in mice, did not result in any immunomodulatory phenotype besides the demonstrated tolerance toward allografts. The predominant expression of coronin 1 in leukocytes and the observation in both mice and human that its deletion appears to exclusively affect naive T cells suggests that compounds targeting coronin 1 or the coronin 1-dependent cAMP pathway may allow effective graft tolerance without overt immunosuppression. Additionally, with the advent of technologies to edit genomes in hematopoietic stem cells, one might consider targeting coronin 1 to promote a tolerogenic milieu in transplant recipients.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Cells
Jurkat cells (ATCC, TIB-152) were grown in RPMI-1640 (Sigma) containing penicillin/streptomycin (GIBCO), 2 mM L-glutamine (GIBCO) and 10% FCS (PAA). Cells were incubated in a 37 C humidified incubator with a 5% CO 2 .
Mice Coro1a À/À (available from The Jackson Laboratory (JAX stock no. 030203)) and WT C57BL/6 mice were described before (Jayachandran et al., 2007) and were used from backcross 8 or backcross 10 to C57BL/6. All cohorts were age-(8-16 weeks) and sex-matched and both males and females used for the studies. RAG2 À/À (Shinkai et al., 1992) and H2-bm12 (I-A bm12 , McKenzie et al., 1979) mice were obtained from Prof. Ed Palmer (Basel, Switzerland). Minor histocompatibility antigen-mismatched mice ('minor' in short) were generated in house by backcrossing four times the F1 (C57BL/6 x BALB/c) progeny to the C57BL/6 parental line. This minor histocompatibility antigen-mismatched donor mouse line was validated for expression of BALB/c and C57BL/6 MHC antigens by flow cytometry that confirmed expression of C57BL/6 MHC molecules and none of the BALB/c MHC molecules ( Figure S1 ). Furthermore, a 1450 single-nucleotide polymorphism (SNP) analysis showed this strain to possess 96.9% of C57BL/6 genome with the rest coming from BALB/c genome (data not shown). OTII transgenic mice (C57BL/6; B6-Tg(TCRaTCRb)425Cbn/J)) were obtained from the Swiss Immunological Mouse Repository (SwimR) and crossed with Coro1a À/À mice. OTII x Coro1a À/À transgenics were backcrossed at least 4 times to parental lines (Barnden et al., 1998) . All animal experimentation was approved by the veterinary office of the Canton of Basel-Stadt (approved license number 1893 and 2326) and performed according to local guidelines (Tierschutz-Verordnung, Basel-Stadt) and the Swiss animal protection law (Tierschutz-Gesetz).
Human Blood Specimens
Human PBMCs were isolated from healthy volunteers (males, 25-35 years old) or the Coro1a À/À individual (male, 20 years old) described earlier (Moshous et al., 2013 ) using a Histopaque 1077 (Sigma Aldrich, #10771) column following the manufacturers protocol.
Bacterial, viral and fungal strains Salmonella typhimurium; SL3261 (vaccine strain with aroA mutation), SL3261/pMW57 (vaccine strain expressing GFP-OVA from the in vivo inducible pagCp promoter) and SL1344 (wild-type virulent strain for challenge infection). Staphylococcus aureus; SH1000 strain for IV studies and SA113 WT for the foreign body infection model studies. Candida albicans; SC5314 strain.
Murine cytomegalovirus; MCMV-DM157 strain.
METHOD DETAILS Reagents
Antibodies used were from the following sources: rabbit a-coronin 1 antibody (serum 1002) has been described before (Ferrari et al., 1999) ; mouse a-coronin 1 was from Abnova (Cat#H00011151-M01) or Abcam (Cat# ab56820). PDE4 antibody was from Abcam (ab14628). cAMP antibody (#sc-73761) and Phospho Thr 196 CaMKIV antibody was from SCBT (SC28443). Anti CD80 (clone 16-10A1), a-CD86 (clone GL-1), hamster Isotype control (clone HTK888) and rat isotype control (clone RTK2071) were from Biolegend. Phospho Ser 133 CREB antibody was from CST (#9196). CFSE and CTV was from Thermo Fisher scientific. All flow cytometry antibodies used were from Biolegend. H89, KN93 were purchased from Tocris Biosciences. Miglyol 812N was from IOI Oleo. DNase I 
Heterotopic cardiac transplantation
Vascularized cardiac allografts were placed in the abdomen of recipient mice according to the method of Niimi et al. (Niimi, 2001) . In brief, hearts from BALB/c donors were heterotopically transplanted into the abdominal cavity of WT and Coro1a À/À recipient (females, 8-10 weeks old) mice under anesthesia with the ascending aorta anastomosed to the native abdominal aorta and main pulmonary artery to the native inferior vena cava, and the pulmonary veins and vena cava of the graft were ligated. Heart graft survival was subsequently monitored daily by palpation, and the day of complete cessation of heartbeat was considered as the day of rejection and was verified by autopsy. Loss of graft function within 48 h of transplant was considered a technical failure (< 5% on average), and these animals were omitted from further analysis.
Skin transplantations and lymphoid organ analysis
Skin biopsies were grafted onto recipient mice following the procedure described before (Schmaler et al., 2014) . In brief, under aseptic conditions, the donor mouse tail skin (1 cm 2 ) was transplanted onto the dorsum, about 2 cm below the ear line, of an anesthetized recipient mouse whose skin had been shaved and a small area (1 cm 2 ) removed to make space for the donor skin graft. The graft was glued using Histo-Acryl (Braun, # 1050052), bandaged and adequate analgesia (buprenorphine (50 mg/kg body weight) for 1 day and paracetamol (3 mg/kg body weight) for the next 5 days in drinking water) was provided. The bandage was removed 7 days later and the animals regularly monitored until the time of study termination depending on the status of the graft. H2-bm12 (I-A bm12 )
tail skin grafts were used for major MHC mismatched studies. Skin grafts for minor histocompatibility-mismatched allograft studies were performed with tail skin from a C57BL/6 mice line ('minor' in short) generated in house by backcrossing four times the F1 (C57BL/6 x BALB/c) progeny to the C57BL/6 parental line (also see ''mice'' in Experimental Models, above). For adoptive transfer experiments, at the time indicated, the different populations of T cells as indicated were injected i.v. as described previously (Siegmund et al., 2011) . In case the animals showed graft removal immediately following bandage removal, poor health and/or aberrant behavior they were excluded from the analysis. Adoptive transfer of cells was performed through tail vein using 200 ml volume of plain phenol red free RPMI using 26G needle-fitted insulin syringes. Application of H89 (40 mg/kg body weight, B.D.) was started a day prior to adoptive transfer in 0.9% saline S.C. and maintained for 8 days, followed up by topical application on the allograft using a mixture of miglyol and kolliphor EL (1:1, 100 mL) to minimize development of rashes at the injection site. For analysis of immune cells, mice were euthanized with CO 2 , and spleen and lymph nodes were harvested in ice cold PBS and smashed through a gridded mesh (steel/nylon (Sefar AG)). The debris were removed by a quick spin (300 xg, 10 s). Spleen cells were treated with Ammonium-ChloridePotassium (ACK) buffer (155mM NH 4 Cl, 10mM KHCO 2 , 1mM EDTA, pH 7.4) or BD FACS lysis buffer (#349202) to remove red blood cells. Cells were counted and stained in FACS buffer (PBS, 2% FCS, 5mM EDTA) with the appropriate antibodies. After incubation (30 min on ice), cells were washed twice with the same buffer and resuspended in 200 ml of FACS buffer. The fluorescence was measured using a BD LSR Fortessa or BD FACS Canto cytometer and results analyzed using FlowJo software (Tree Star).
Immune cell infiltration inside allografts
The allografts were dissected out on day 8 post-surgical implantation on recipient mouse, minced into small pieces and incubated in digestion cocktail (Iscove's modified Dulbecco's medium containing DNase I (0.1 mg/mL), collagenase type I (3.3 mg/mL) and hyaluronidase type IV-S (1 mg/mL) (all from Sigma-Aldrich, St Louis, MO, USA) in a shaker bath at 37 C for 90 min. The digested skin was subsequently crushed between Sefar mesh and filtered through a 30 mM pre-separation filter (Miltenyi Biotech), surface stained and assessed by flow cytometry.
T cell isolation
For biochemical experiments T cells were purified from spleen by means of immuno-magnetic negative selection using total, CD4 or CD8 T cell isolation kits (Stemcell technologies) following the manufacturers protocol. The purity of the T cells used in any of the biochemical procedure mentioned was $90% (as assessed by flow cytometry). For adoptive transfer experiments: T cells for adoptive transfer experiments were purified either by means of immuno-magnetic negative selection using total CD4 or CD8 T cell isolation kits (Stemcell technologies) or by means of surface staining and positive selection using flow cytometry-based cell sorting (BD FACS Aria). Depletion of CD25 + T cells was performed by addition of biotinylated anti CD25 antibody (clone PC61, Biolegend) followed by addition of streptavidin beads and magnetic separation. The cells were re-suspended to appropriate numbers as mentioned in the Figure legend and injected intravenously through the tail vein in a volume of 200 ml/mouse. The purity of WT T cells and Coro1a À/À T cells used for adoptive transfer experiments were over 90% as assessed by flow cytometry.
Treg cell depletion protocol
Depletion of Treg cells with a-CD25 antibody (clone PC61) administration was performed as described in Siegmund et al. (Siegmund et al., 2011) . In brief, Coro1a À/À mice and RAG2 À/À controls that had been transplanted with minor histocompatibility antigen-mismatched skin transplant were subjected to a-CD25 antibody (clone PC61, 0.5 mg/mouse IP) administration to deplete regulatory T cells (on D-5, D-3). Coro1a À/À mice were subsequently bled on various days (D-5, D0, D21, D35 and D65) to assess the efficacy of PC61 mediated CD25 + T cell depletion by a-CD25 antibody (clone 7D4) and re-administration of PC61 timed when an increase in Treg cell population was observed (on D36 and D66).
In vivo homeostatic proliferation inhibition
The protocol was adapted from Sojka et al. (Sojka et al., 2009 Figure 3F , CD62L status was omitted and 1 million each of Ly5.1 and Ly5.2 cells were injected through the tail vein and analyzed on day 14.
Cell lysis and immunoblotting
Cells or tissues were lysed in Triton X-100 buffer with 0.2% SDS containing protease and phosphatase inhibitors (Roche) at 4 C as described (Jayachandran et al., 2014) , followed by protein determination (BCA, Pierce) and SDS-PAGE, transferred onto nitrocellulose and probed using the indicated antibodies followed by HRP-labeled secondary antibodies and developed using an enhanced chemi-luminescence imager (Fuji) as described before (Tulp et al., 1994) or using an IR dye tagged secondary antibody and imaged using a LI-COR imaging system.
Immunofluorescence analysis
Splenic T cells were fixed in PFA (4%) immediately for 20 min, followed by washing and saponin permeabilization (15 min 0.5%) when indicated. Following 30 min blocking with 2% BSA in PBS, cells were incubated with primary antibodies (1:1000, 1 h RT or overnight at 4 C) followed by Alexa Fluor 488 or À568 labeled secondary antibody incubation at room temperature for 1h. Jurkat cells were seeded on Poly-L-Lysine-coated, 10 well Teflon-coated slide (Thermo) for 1h at 37 C with 5% CO 2 . The fixation was done with ice-cold 3% methanol, followed by washing in PBS-Dulbecco and blocked for 20 min with PBS-Dulbecco containing 5% FCS. The cells were then stained for coronin 1 using a-coronin 1 antibody (Abcam, 1:100 diluted in PBS-D/2%FCS) for 30 min at RT followed by Alexa fluor À568 conjugated secondary antibody (1:400, diluted in PBS-D/2% FCS) for 30 min at RT. DRAQ-5 (Biostatus) (1:1500, diluted in PBS-D/2% FCS) was used for 15 min at RT. Slides were analyzed using a LSM510 Meta confocal laser scanning microscope (Zeiss).
cAMP measurement
Total splenic T cells were isolated with the T cell isolation Kit (Stemcell technologies), according to the manufacturer's instruction. Cells were incubated with either DMSO or 100 mM rolipram (Tocris, #0905) in PBS/2% FCS/2 mM EDTA for 30 min at 37 C, 5% CO2. Cells were then stimulated with 100 mM forskolin (Tocris, #1099) for 10 min at 37 C and lysed with Lysis Buffer/D2 solution from the HTRF cAMP femto 2 Kit (CisBio, #62AM5PEB) in 1.5 mL Eppendorf tubes. Lysates were then transferred to 384 plates (Greiner, #781075), Lysis Buffer/CC was added to each well and topped up with PBS/2% FCS/2 mM EDTA to a 20 ml final volume. Plates were incubated for 1 h at RT in the dark and measured on a Tecan Infinite F500 reader. Alternatively, cAMP levels were determined using a cAMP ELISA kit following the manufacturers protocol (R&D systems, # SKGE002).
Protein kinase A activity measurement PKA activity was measured using the PeptagÒ non-radioactive cAMP-dependent protein kinase as described before (Jayachandran et al., 2014) . In brief, the non-radioactive PepTag PKA assay (Promega) was used to measure PKA activity from equal protein amounts of T cell lysates prepared in PKA extraction buffer (25 mM Tris-HCl (pH 7.4), 0.5 mM EDTA, 0.5 mM EGTA, 10 mM b-mercaptoethanol, 1 mg/mL leupeptin, 1 mg/mL aprotinin and 100 mM PMSF) to measure activity based on the phosphorylation of the fluorescent PKA substrate peptide, Leu-Arg-Arg-Ala-Ser-Leu-Gly (Kemptide), which, upon phosphorylation by PKA, acquires a negative charge and can be separated from the non-phosphorylated peptide by agarose gel electrophoresis. The in vitro phosphorylation of kemptide was performed for 30 min at 30 C in a PCR machine, after which the samples were cooled to 4 C, run on agarose gels and the phosphorylated band intensity quantitated and processed using ImageJ for assessment of PKA activity.
Genomic deletion of Coro1a in Jurkat T cells by CRISPR-Cas9 Genome Editing pSpCas9(BB)-2A-GFP (PX458) was a gift from Feng Zhang (Addgene plasmid # 48138). A 20-nucleotide sequence followed by a protospacer adjacent motif (PAM) from Streptococcus pyogenes targeting the third exon of human Coro1a was selected using publicly available tools: TTCATAGCACTGGTCGGCCTTGG as guide sequence was selected for the least number of potential off-target sites. The sequence was cloned into PX458 as previously described (Ran et al., 2013) . Jurkat T cells (2x10 6 ) were electroporated with 20 mg of pX458-sgRNA plasmid at 250 V for 5 ms using the Neon electroporation system (Invitrogen). GFP-expressing cells were sorted 48 h post-electroporation to enrich for transfected cells. Sorted cells were plated clonally at limiting dilution and screened by immunofluorescence staining against coronin 1. The absence of coronin 1 expression was further confirmed by immunoblotting.
Jurkat membrane fractionation and adenylate cyclase activity analysis Jurkat cells were pelleted (200 xg/5 0 /4 C) and washed with Homogenization Buffer (HB) (10 mM Triethanolamine, 10 mM Acetic Acid, 1 mM EDTA, 0.25M Sucrose pH 7.4 supplemented with 50 mM NaF, 5 mM Na3Vo4 and Protease Inhibitors (Roche cOmplete #11873580001)) and resuspended in HB. Cells were homogenized using a 27G needle and homogenization was assessed under a microscope with trypan blue. Homogenate was then spun down for 10' at 1000 xg 4 C and post-nuclei supernatant transferred to a fresh ultracentrifuge 1.5 mL tube followed by another centrifugation for 30 min at 100'000 xg. The resulting membrane pellet was carefully resuspended with a 21G needle in 75 mM Tris pH 7.4, 12.5 mM MgCl 2 , 1 mM EDTA supplemented with protease/phosphatase inhibitors (ThermoFisher HALT cocktail #78420). Protein concentrations were assessed by BCA and equal mg of membranes were spun down for 15 min at 21'000 xg. The resulting pellet was resuspended in adenylate cyclase buffer (25 mM Tris pH 7.4, 5 mM MgCl 2 , 1 mM EGTA, 1 mM DTT, 0.1 mg/mL BSA, 5 mM ATP) and stimulated with 100 mM FSK for 15 min at room temperature and the cAMP produced determined either using the cAMP HTRF kit or the cAMP ELISA as described under cAMP measurement.
Human PBMC and cAMP
For cAMP analysis, the isolated cells were subsequently analyzed by flow cytometry to characterize the various immune cell subtypes based on antibody staining for CD3, CD4, CD8, CD19 and CD25. Subsequently, these cells were serum starved for 2 h and subjected to 100 mM FSK stimulation and cAMP production assessed as shown in the section on cAMP measurement.
RNA sequencing analysis WT or Coro1a
À/À conventional T cells (CD4 + CD25 -) were enriched from spleen by negative isolation using the CD4 + T cells isolation kit (Stemcell technologies) followed by depletion of CD25 + T cells using biotinylated a-CD25 antibodies. Regulatory T cells (CD4 + CD25 + ) were purified from spleen and lymph nodes of WT or Coro1a À/À mice by means of immuno-magnetic positive selection kit (Stemcell technologies) following the manufacturers protocol. The purity of conventional and regulatory T cells was over 90% (as assessed by flow cytometry). Total cellular RNA was isolated using TRIzol (Sigma), and the library generated with the Illumina TruSeq mRNA LT kit (poly-adenylated mRNA enriched) was sequenced in single read mode on an Illumina NextSeq 500 sequencing platform. Adaptor-trimmed reads were aligned to the Mus musculus genome (Ensembl GRCm38) using STAR (Dobin et al., 2013) . Read counts were summarized using htseq-count from the HTSeq package in union mode (Anders et al., 2015) . Differential expression analysis was conducted using DESeq2 using a full model incorporating the effects of genotype, cell type, and the interaction of these variables with a cut-off of adjusted p values < 0.05 (Love et al., 2014; Robinson et al., 2010; Yu and He, 2016; Yu et al., 2012) . The PCA clustering of transcriptomes shown in Figure 3E was essentially identical when based on expression for all detected transcripts or those found to be differentially expressed.
Graft versus Host Disease (GvHD) analysis
Assessment of GvHD responses were performed as detailed in (Krenger et al., 2000a; Krenger et al., 2000b) . In brief, total T cells were isolated from WT or Coro1a À/À C57BL/6 (I-A b ) mice by means of negative selection using Stem cell technologies kit (#19851) followed by CD25 + T cell depletion (see T cell isolation for adoptive transfer for more details). The isolated cells were transferred intravenously (20 x10 6 cells) by means of tail vein injection into recipient BDF1 (I-A bd ) mice and kinetics of GvHD monitored. The parameters observed were weight loss, fur changes, immobility, skin rash, hair loss and loose stools. When the mice reached a weight loss of 20% the initial weight at day 0, the study was terminated and internal organs assessed for gross organomegaly, lymphadenopathy and thymic atrophy. The thymus was isolated, single cells prepared and stained for the CD3, CD4, CD8, TCRa and a viability marker to assess the double and single positive status along with cell viability and enumeration of total cell numbers. BDF1 mice receiving total splenocytes (35 x10 6 cells), either from C57BL/6 (I-A b ) Ly5.1 mice or BDF1 (I-A bd ) mice served as positive (acute GvHD) and negative (no GvHD) controls.
In vitro T cell proliferation WT or Coro1a À/À T cells isolated using the negative total T cell isolation kit (Stem cell technologies) were seeded on 96 well round bottom wells (2 3 10 5 cells/ well) at a final volume of 200 ml of RPMI supplemented with 10% FCS and penicillin-streptomycin (Sigma) and L-glutamine (Sigma) with plate-bound CD3 (Biolegend, 10ug/mL in PBS for 2 h at 37 C) and soluble a-CD28 (Biolegend, 2ug/mL) either in the presence of the PKA inhibitor H89 (1 mM, Tocris), the CaMKIV inhibitor KN93 (10 mM, Tocris), rolipram (5-1280 mM, Sigma) or vehicle only control. At the 48 h time point, 1 mCi of tritiated thymidine was added to all wells and further incubated for 20 h followed by harvesting on a GF/C filter and measuring the DNA incorporated counts using a Packard instrument as a measure of T cell proliferation. Alternatively, T cells labeled with cell trace violet (CTV) were used and proliferation assessed by flow cytometry for CTV dilution.
Mixed Lymphocyte Reaction (MLR) in the presence of elevated cAMP Total splenocytes were isolated from BALB/c mice (I-A d ), depleted of RBC using ACK lysis buffer (NH 4 Cl (155 mM), KHCO2 (10 mM)
and EDTA (1 mM)), counted and seeded in 12 well plate at 2 million cells/well in 2ml of APC medium (10% FCS containing DMEM with PSG (1x), Na-pyruvate (1x), NEAA (1x), L-Glutamine (1x) and b-ME (50 mM)). 24 hours later, these cells were collected, washed, counted and seeded at 0.1 million cells/well of a 96 well plate along with 0.1 million of CTV labeled C57BL/6 (I-A b ) WT T cells (purified using Total T cell isolation Kit, Stemcell Technologies) in 200 ml volume of T cell medium (10% FCS containing RPMI with PSG (1x) + Na-pyruvate (1x) + NEAA (1x) + L-Glutamine (1x) + b-ME (50 mM)) in the presence of blocking antibodies (a-CD80; 10 mg/mL and/or a-CD86; 10 mg/mL) or isotype controls (Iso Ctrl). Rolipram (10 mM) or DMSO controls were added in appropriate wells and after 84 h, the CD4 T cells were analyzed by flow cytometry for CTV dilution and analyzed using FlowJo (TreeStar).
Mixed Lymphocyte Reaction (MLR) with WT and Coro1a
-/-APCs Splenocytes were isolated from WT and Coro1a À/À mice C57BL/6 (I-A b ), depleted of RBC using ACK lysis buffer and used as APCs.
the mice were infected with either the normal Salmonella (SL3261, 10 9 bacilli, gastric inoculation) or GFP-OVA expressing Salmonella SL3261/pMW57 (10 9 bacilli, gastric inoculation, vaccine strain expressing GFP-OVA from the in vivo inducible pagCp promoter; Bumann, 2001) . The proliferation of transferred OT II T cells was monitored on day 7 from Payer's patches and mesenteric lymph nodes by flow cytometry. For the assessment of OVA-specific responses only those OTII cells that were labeled for CTV (CTV low versus CTV high ) were considered. In parallel, on day 7 the CFUs were enumerated from spleen and liver.
Blood biochemistry profile analysis
The animals were sacrificed in a carbon dioxide chamber and immediately afterward a cardiac puncture was performed and blood was aspirated and subjected to analysis in the biochemistry laboratory of the University Hospital Basel and the results compiled.
Analysis of microbiota in internal organs
For the analysis of various aerobic and anaerobic microbial floras in internal organs of the aged mice (> 30 weeks), the mice were sacrificed in a carbon dioxide chamber followed by dissection of the mice under sterile conditions for isolation of the duodenum and caecum. The organs were immediately minced into multiple small pieces in 500 ml of sterile peptone water and a homogeneous suspension was prepared. Various dilution of the suspension was plated in blood agar (aerobic and anaerobic conditions), McConkey agar (Enterobactericeae), Endoagar (Enterobactericeae), chromagar (Gram-positive bacteriae) or Sabouraud agar (yeast and fungi). Appropriate incubation conditions were provided for both aerobic and anaerobic condition for 24-48 h after which the colonies appearing were isolated and further identified by routine bacteriological characterization methods (MicroBioS GmbH, Switzerland).
Aging and life expectancy studies Age and sex matched WT and Coro1a À/À deficient mice (40 males and 40 females of either genotype) were housed in conventional animal cages (Techniplast) in groups of maximum 4 animals per cage and provided water and food ad libitum. They were scored regularly during their lifespan and monitored for general health status (grooming status, personal hygiene, discharge of purulent fluids from eyes, nose, anus, urethra, and skin rashes), altered stool stains in the holding cages, mobility, abdominal swelling, abnormal growth and fur changes. When mice became moribund due to aging, they were sacrificed and internal organs analyzed for organomegaly, cysts, nodular deposits and hemorrhagic ascites. Histological assessment of any affected organ was performed as needed (Microbios GmBH).
Analysis of viral pathogens
For the analysis of various viral pathogens, aged mice (> 30 weeks) were sacrificed in a carbon dioxide chamber and cardiac puncture was performed immediately to withdraw blood. The blood was allowed to clot and the serum was separated and the titer of antibodies against various common mouse viral pathogens investigated as shown in table S1 (MicroBioS GmbH, Switzerland).
Histopathological analysis of various organs
For the analysis of various internal organs of the aged mice (> 30 weeks), the mice were sacrificed in a carbon dioxide chamber followed by dissection of the mice under sterile conditions for isolation of the various internal solid organs including the liver, spleen, lungs, heart, pancreas, kidney and brain. The isolated organs were fixed in 4% formalin, sectioned and histochemistry analysis performed to assess any histological changes associated with malignant changes (MicroBioS GmbH, Switzerland).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses
Statistical analyses were performed with Prism (GraphPad Software) and Excel (Microsoft office). Gene ontology was performed using Panther (http://www.pantherdb.org/panther/ontologies.jsp. Comparisons between two groups were performed with the unpaired Student's t test or the Mann-Whitney U-test (when the groups were independent and did not have a normal distribution) or using Log-rank (Mantel Cox analysis) for graft survival analysis. P values: * p < 0.05, ** p < 0.01, ***p < 0.001 and ****p < 0.0001. Error bars normally show standard deviation unless standard error margin is mentioned.
DATA AVAILABILITY
Data will be available from the Gene Expression Omnibus (GEO; GSE122567).
